Conestoga Capital Advisors Sells All Azenta Inc Shares

Conestoga Capital Advisors sold its entire position in Azenta Inc, a U.S. life science company specializing in biological and chemical compound sample management, during the second quarter of 2026. The asset management firm exited the investment after Azenta management lowered the company's full-year outlook.

Conestoga attributed the decision to a combination of execution challenges, weak funding within the life sciences sector, and continued softness in capital equipment demand. While the firm acknowledged that Azenta is currently implementing operational improvements, it concluded that the company's recovery would likely take longer than originally anticipated.

As of August 5, 2026, Azenta shares closed at $31.82, representing a market capitalization of $1.47 billion.